Holen Sie sich die Stockscreener-App
6.66
0.45%
0.03
Vorhandelsmarkt:
6.67
0.010
+0.15%
Schlusskurs vom Vortag:
$6.63
Offen:
$6.61
24-Stunden-Volumen:
6.07M
Relative Volume:
1.04
Marktkapitalisierung:
$1.20B
Einnahmen:
$2.51B
Nettoeinkommen (Verlust:
$-171.15M
KGV:
-6.9137
EPS:
-0.9633
Netto-Cashflow:
$122.59M
1W Leistung:
+11.00%
1M Leistung:
+26.38%
6M Leistung:
-17.37%
1J Leistung:
-6.85%
1-Tages-Spanne:
$6.55
$6.795
1-Wochen-Bereich:
$5.23
$6.795
52-Wochen-Spanne:
$4.40
$9.77
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, BTSG, TEM, HQY, DOCS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
6.66 | 1.20B | 2.51B | -171.15M | 122.59M | -0.9633 |
VEEV
Veeva Systems Inc
|
171.19 | 27.94B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
51.44 | 9.98B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
54.07 | 9.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.63 | 6.98B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
25.77 | 4.76B | 637.78M | 239.40M | 307.21M | 1.1909 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-02-26 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-07-25 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Teladoc Virtual Care Shift Reshapes Russell 1000 Index View - Kalkine Media
Virtual care accelerates accessibility as Teladoc Health, Inc. targets improved outcomes - Traders Union
Barclays Maintains Teladoc Health(TDOC.US) With Hold Rating, Maintains Target Price $7 - Moomoo
AI in Telemedicine Market to Reach USD 193.30 Billion by 2033 as - openPR.com
Earnings snapshot: Teladoc Health issues weak Q2 revenue outlook after mixed Q1 results - MSN
TDOC Q1 Earnings Miss, Revenues Down Y/Y on BetterHelp Weakness - TradingView
Is It Time To Reconsider Teladoc Health (TDOC) After The Recent Share Price Rebound? - Sahm
Teladoc Health, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:TDOC) 2026-05-03 - Seeking Alpha
Teladoc Q1 preview: Profits seen improving, BetterHelp operations in focus - MSN
Why Is Teladoc (TDOC) Stock Soaring Today - Yahoo Finance
Are These Beaten-Down Stocks Generational Opportunities or Value Traps? - AOL.com
Teladoc Health Q1 2026 Results: Revenue Beat, Sales Drop, and AI-Driven Forward GuidanceNews and Statistics - IndexBox
HIMS vs. TDOC: Which digital health stock offers better upside now? - MSN
Teladoc Health Q1 Earnings Call Highlights - MarketBeat
TDOC Q1 Deep Dive: AI-Enabled Product Rollout and Insurance Expansion Drive Strategic Shifts - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Teladoc Health (NYSE:TDOC) Stock Price Up 7.7%Here's Why - MarketBeat
TDOC SEC FilingsTeladoc Health Inc 10-K, 10-Q, 8-K Forms - Stock Titan
UHS, Acadia, Teladoc Plot Course for 2026 - Behavioral Health Business
Teladoc Health Target of Unusually Large Options Trading (NYSE:TDOC) - MarketBeat
Analysts Are Bullish on These Healthcare Stocks: Teladoc (TDOC), Pfizer (PFE) - The Globe and Mail
Teladoc Q4 earnings: Can integrated care strength save profits? - MSN
Teladoc Health Exceeds Revenue Guidance Driven by Integrated Care - HarianBasis.co
Jefferies raises Teladoc stock price target to $6 on Q1 results - Investing.com
TDOC Stock Price, Quote & Chart | TELADOC HEALTH INC (NYSE:TDOC) - ChartMill
TDOC SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus
Teladoc Earnings Call: Insurance Momentum Amid Headwinds - TipRanks
Investment Opportunities in Teladoc and PayPal - Intellectia AI
Teladoc Health Q1 2026 revenue down 2% to USD 613.8M - Medical Buyer
HIMS vs. TDOC: Which Digital Health Stock Offers Better Upside Now? - The Globe and Mail
Vanguard reports 9.21M Teladoc shares (TDOC) as 5.16% stake - Stock Titan
Truist Financial Maintains Teladoc Health(TDOC.US) With Hold Rating - Moomoo
Evercore Maintains Teladoc Health(TDOC.US) With Hold Rating, Maintains Target Price $6 - Moomoo
Teladoc (TDOC) Q1 2026 Earnings Transcript - AOL.com
Teladoc Health (NYSE:TDOC) Shares Gap Down on Disappointing Earnings - MarketBeat
How Teladoc’s Narrower Q1 Loss Amid Softer Revenue At Teladoc Health (TDOC) Has Changed Its Investment Story - Yahoo Finance
Teladoc Health (TDOC) narrows Q1 2026 loss as Integrated Care grows - Stock Titan
Teladoc Stock Slides Following Q1 Earnings Miss, Lower Guidance - Benzinga
A Quick Look at Today's Ratings for Teladoc Health(TDOC.US), With a Forecast Between $6 to $10 - Moomoo
Teladoc Health, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
BofA raises Teladoc stock price target on insurance transition By Investing.com - Investing.com Canada
Retailers shift healthcare strategy to GLP-1s after clinic setbacks - Modern Healthcare
Teladoc Health (TDOC) Reports Strong Q1 2026 Earnings Performanc - GuruFocus
Teladoc Health Q1 2026 Earnings Call Transcript - MarketBeat
Earnings Call Summary | Teladoc Health(TDOC.US) Q1 2026 Earnings Conference - Moomoo
TDOC News | TELADOC HEALTH INC (NYSE:TDOC) - ChartMill
Responsive Playbooks and the TDOC Inflection - Stock Traders Daily
How Teladoc’s Slower Revenue but Narrower Losses Will Impact Teladoc Health (TDOC) Investors - simplywall.st
Teladoc Health (TDOC) Reports Q1 Earnings Miss, Stock Drops 5% i - GuruFocus
Teladoc Health (NYSE:TDOC) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
TDOC Projects Q2 Revenue Between $597M and $626M - GuruFocus
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.66%
1.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):